News

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage oncology company leveraging its proprietary RADR ® artificial intelligence (AI) platform to accelerate drug discovery, today announced that the ...
Lockheed Martin has announced a successful flight demonstration of a new AI-enabled Synthetic Aperture Radar (SAR) system, ...